<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE318nnn/GSE318357/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318357</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Bulk liver mRNA-seq of Cep72 knockout and wild-type mice in Schistosoma japonicum infection–induced and CCl4-induced liver fibrosis models</name><description>Liver fibrosis is a common pathological outcome of chronic liver injury triggered by diverse etiologies. To investigate the role of CEP72 in fibrogenesis under distinct fibrotic settings, we performed bulk mRNA sequencing of whole-liver total RNA from wild-type (WT) and Cep72 knockout (Cep72-KO) mice in two experimental models: Schistosoma japonicum (Sj) infection–induced liver fibrosis and carbon tetrachloride (CCl4)–induced liver fibrosis. For the Sj model, mice were percutaneously infected with 17 ± 1 Schistosoma japonicum cercariae per mouse and analyzed at 8 weeks post infection, generating four groups: 8W-NC (WT control), 8W-KO-NC (Cep72-KO control), 8W-Sj (WT + Sj infection), and 8W-Sj-KO (Cep72-KO + Sj infection) (n = 2 mice per group). For the CCl4 model, mice were treated for 8 weeks with intraperitoneal injections of 10% CCl4 at 10 μL/g body weight, twice per week, and samples were collected from 8W-CCL4 (WT + CCl4) and 8W-KO-CCL4 (Cep72-KO + CCl4) groups (n = 2 mice per group). Paired-end Illumina mRNA-seq was performed on extracted total RNA from whole liver tissue. This dataset enables comparative transcriptomic analyses to identify CEP72-associated gene expression programs and pathways involved in liver injury, inflammation, and fibrosis across parasitic and chemical models.</description><dates><publication>2026/07/01</publication></dates><accession>GSE318357</accession><cross_references><GSM>GSM9493162</GSM><GSM>GSM9493161</GSM><GSM>GSM9493172</GSM><GSM>GSM9493171</GSM><GSM>GSM9493170</GSM><GSM>GSM9493166</GSM><GSM>GSM9493165</GSM><GSM>GSM9493164</GSM><GSM>GSM9493163</GSM><GSM>GSM9493169</GSM><GSM>GSM9493168</GSM><GSM>GSM9493167</GSM><GPL>34290</GPL><GSE>318357</GSE><taxon>Mus musculus</taxon><PMID>[42087233]</PMID></cross_references></HashMap>